Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Modulation of gut microbiota composition refers to the intentional alteration—through dietary interventions, probiotics/prebiotics/synbiotics/postbiotics administration, fecal transplants, or other means—of the complex community structure and function within the human gastrointestinal tract. The gut microbiota is not a single molecule or receptor but rather a diverse ecosystem comprising bacteria, fungi, archaea, viruses and their collective genes. This ecosystem plays essential roles in digestion/metabolism; maintenance of mucosal barrier integrity; development/regulation of immunity; production/modification/absorption/excretion/metabolism-of-nutrients-and-drugs; synthesis-of-neuroactive-compounds-affecting-the-gut-brain-axis; modulation-of-inflammation-and-host-defense-mechanisms. Dysbiosis—a disruption in this balance—is implicated in numerous diseases including neurodegenerative disorders like Parkinson’s disease and Alzheimer’s disease, cardiovascular conditions, metabolic syndrome, gastrointestinal disorders such as colitis/inflammatory bowel diseases, among others. While “modulation” itself is not a molecular target but rather an approach/strategy/intervention area aimed at restoring healthy homeostasis by shifting microbial populations/functions toward beneficial profiles—it is increasingly recognized as both a diagnostic marker set (“microbial signatures”) and therapeutic avenue. Note on correctness: “Modulation of gut microbiota composition” does not refer to a specific molecule/receptor/protein/enzyme/transporter/etc.; it describes an intervention strategy targeting an entire ecological system. Therefore it should not be classified as a canonical drug target per se. If you need information about specific molecular targets involved in modulating the gut microbiome (such as receptors mediating microbe-host interactions), please specify further.
Restoration or alteration of microbial community structure to a healthy state by increasing beneficial bacteria and/or reducing pathogenic species. Modulation of microbial metabolites such as short-chain fatty acids and bile acids that influence host physiology and immune responses. Reduction in inflammation via changes in microbial-derived molecules or immune signaling pathways (e.g., suppression of oxidative stress).
5 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Modulation of gut microbiota composition.